Literature DB >> 8553298

Excessive thoracic computed tomographic scanning in sarcoidosis.

J Maña1, A S Teirstein, D S Mendelson, M L Padilla, L R DePalo.   

Abstract

BACKGROUND: The clinical value of computed tomographic (CT) scanning of the chest in the initial assessment of sarcoidosis was investigated.
METHODS: One hundred consecutive patients referred to the sarcoidosis outpatient services of the Mount Sinai Medical Center, New York from 1990 to 1992 with a presumptive diagnosis of sarcoidosis were studied. The diagnosis was subsequently confirmed in all by a positive tissue biopsy sample or the Kveim-Siltzbach test. Clinical and laboratory data of each patient were reviewed. Chest radiographs were classified according to the classical stages of sarcoidosis. Thirty five of the 100 patients had a CT scan of the chest performed before presentation. The CT scans were compared with the presenting clinical data and standard chest radiographs in order to determine if they yielded useful additional information regarding diagnosis or treatment.
RESULTS: The chest CT scan revealed no additional clinically relevant information compared with conventional chest radiographs in any of the 35 studies performed. In two patients mediastinal adenopathy was detected by CT scan which was not seen on standard radiographs. Two patients thought to exhibit hilar adenopathy and pulmonary infiltrations by standard radiography had no parenchymal disease on the CT scan. Bilateral parenchymal infiltrates were seen in one patient which were interpreted as unilateral infiltrates by standard radiographs. The variance between conventional radiographs and CT scans in these five patients was not clinically valuable.
CONCLUSIONS: CT scans of the chest do not add clinically useful information to the standard chest radiographs in the initial assessment of sarcoidosis in patients presenting with the typical standard radiological patterns. CT scanning of the thorax is indicated in patients with proven or suspected sarcoidosis when the standard chest radiographs are normal or not typical of sarcoidosis, when signs or symptoms of upper airway obstruction are present, when the patient has haemoptysis, if there is a suspicion of a complicating second intrathoracic disease, or the patient is a candidate for lung transplantation.

Entities:  

Mesh:

Year:  1995        PMID: 8553298      PMCID: PMC1021348          DOI: 10.1136/thx.50.12.1264

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  22 in total

Review 1.  Pulmonary sarcoidosis: what are we learning from CT?

Authors:  J H Austin
Journal:  Radiology       Date:  1989-06       Impact factor: 11.105

2.  The CT findings of pulmonary sarcoidosis: analysis of 25 patients.

Authors:  N L Müller; P Kullnig; R R Miller
Journal:  AJR Am J Roentgenol       Date:  1989-06       Impact factor: 3.959

3.  Sarcoidosis: correlation of extent of disease at CT with clinical, functional, and radiographic findings.

Authors:  N L Müller; J B Mawson; J R Mathieson; R Abboud; D N Ostrow; P Champion
Journal:  Radiology       Date:  1989-06       Impact factor: 11.105

4.  Sarcoidosis: correlation of pulmonary parenchymal pattern at CT with results of pulmonary function tests.

Authors:  C J Bergin; D Y Bell; C L Coblentz; C Chiles; G Gamsu; N R MacIntyre; R E Coleman; C E Putman
Journal:  Radiology       Date:  1989-06       Impact factor: 11.105

5.  Clinical interpretation of bilateral hilar adenopathy.

Authors:  R H Winterbauer; N Belic; K D Moores
Journal:  Ann Intern Med       Date:  1973-01       Impact factor: 25.391

6.  Diffuse peripheral lung disease: evaluation by high-resolution computed tomography.

Authors:  H Nakata; T Kimoto; T Nakayama; M Kido; N Miyazaki; S Harada
Journal:  Radiology       Date:  1985-10       Impact factor: 11.105

7.  Typical and atypical CT manifestations of pulmonary sarcoidosis.

Authors:  U M Hamper; E K Fishman; N F Khouri; C J Johns; K P Wang; S S Siegelman
Journal:  J Comput Assist Tomogr       Date:  1986 Nov-Dec       Impact factor: 1.826

8.  Computed tomography in pulmonary sarcoidosis.

Authors:  D A Lynch; W R Webb; G Gamsu; M Stulbarg; J Golden
Journal:  J Comput Assist Tomogr       Date:  1989 May-Jun       Impact factor: 1.826

9.  CT in the diagnosis of interstitial lung disease.

Authors:  C J Bergin; N L Müller
Journal:  AJR Am J Roentgenol       Date:  1985-09       Impact factor: 3.959

10.  Pulmonary sarcoidosis: changes on follow-up CT examination.

Authors:  J Murdoch; N L Müller
Journal:  AJR Am J Roentgenol       Date:  1992-09       Impact factor: 3.959

View more
  6 in total

Review 1.  Imaging aspects of the diagnosis of sarcoidosis.

Authors:  Paolo Spagnolo; Nicola Sverzellati; Athol U Wells; David M Hansell
Journal:  Eur Radiol       Date:  2014-01-08       Impact factor: 5.315

Review 2.  The Clinical Features of Sarcoidosis: A Comprehensive Review.

Authors:  Marc A Judson
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

3.  Outcome measures of the 6 minute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosis.

Authors:  Esam H Alhamad; Shaffi Ahmad Shaik; Majdy M Idrees; Mohammed O Alanezi; Arthur C Isnani
Journal:  BMC Pulm Med       Date:  2010-08-09       Impact factor: 3.317

Review 4.  Laboratory support in the diagnosis of uveitis.

Authors:  Parthopratim Dutta Majumder; S Sudharshan; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2013-06       Impact factor: 1.848

5.  Clinical characteristics and computed tomography findings in Arab patients diagnosed with pulmonary sarcoidosis.

Authors:  Esam H Alhamad; Mohammed O Alanezi; Majdy M Idrees; Mohammad K Chaudhry; Ali M AlShahrani; Arthur Isnani; Shaffi Shaikh
Journal:  Ann Saudi Med       Date:  2009 Nov-Dec       Impact factor: 1.526

6.  Admixture fine-mapping in African Americans implicates XAF1 as a possible sarcoidosis risk gene.

Authors:  Albert M Levin; Michael C Iannuzzi; Courtney G Montgomery; Sheri Trudeau; Indrani Datta; Indra Adrianto; Dhananjay A Chitale; Paul McKeigue; Benjamin A Rybicki
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.